175 related articles for article (PubMed ID: 33785838)
1. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted hit identification using pharmacophore screening.
Volynets GP; Starosyla SA; Rybak MY; Bdzhola VG; Kovalenko OP; Vdovin VS; Yarmoluk SM; Tukalo MA
J Comput Aided Mol Des; 2019 Nov; 33(11):955-964. PubMed ID: 31691918
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent anti-tuberculosis agents targeting leucyl-tRNA synthetase.
Gudzera OI; Golub AG; Bdzhola VG; Volynets GP; Lukashov SS; Kovalenko OP; Kriklivyi IA; Yaremchuk AD; Starosyla SA; Yarmoluk SM; Tukalo MA
Bioorg Med Chem; 2016 Mar; 24(5):1023-31. PubMed ID: 26822568
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
Das R; Mehta DK
Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
[TBL] [Abstract][Full Text] [Related]
5. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
6. A consequence of drug targeting of aminoacyl-tRNA synthetases in Mycobacteriumtuberculosis.
Ndagi U; Kumalo HM; Mhlongo NN
Chem Biol Drug Des; 2021 Sep; 98(3):421-434. PubMed ID: 33993612
[TBL] [Abstract][Full Text] [Related]
7. Identification of dual-targeted
Volynets GP; Usenko MO; Gudzera OI; Starosyla SA; Balanda AO; Syniugin AR; Gorbatiuk OB; Prykhod'ko AO; Bdzhola VG; Yarmoluk SM; Tukalo MA
Future Med Chem; 2022 Sep; 14(17):1223-1237. PubMed ID: 35876255
[No Abstract] [Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
9. Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.
Verma SK; Verma R; Verma S; Vaishnav Y; Tiwari SP; Rakesh KP
Eur J Med Chem; 2021 Jan; 209():112886. PubMed ID: 33032083
[TBL] [Abstract][Full Text] [Related]
10. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
11. Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among
Kovalenko OP; Volynets GP; Rybak MY; Starosyla SA; Gudzera OI; Lukashov SS; Bdzhola VG; Yarmoluk SM; Boshoff HI; Tukalo MA
Medchemcomm; 2019 Dec; 10(12):2161-2169. PubMed ID: 32206244
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
[TBL] [Abstract][Full Text] [Related]
13. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
[TBL] [Abstract][Full Text] [Related]
14. Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis.
Bakal RL; Gattani SG
Eur J Med Chem; 2012 Jan; 47(1):278-82. PubMed ID: 22088956
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
[TBL] [Abstract][Full Text] [Related]
17. Boulton-Katritzky Rearrangement of 5-Substituted Phenyl-3-[2-(morpholin-1-yl)ethyl]-1,2,4-oxadiazoles as a Synthetic Path to Spiropyrazoline Benzoates and Chloride with Antitubercular Properties.
Kayukova L; Vologzhanina A; Praliyev K; Dyusembaeva G; Baitursynova G; Uzakova A; Bismilda V; Chingissova L; Akatan K
Molecules; 2021 Feb; 26(4):. PubMed ID: 33673047
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
Bouz G; Zitko J
Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
Palencia A; Li X; Bu W; Choi W; Ding CZ; Easom EE; Feng L; Hernandez V; Houston P; Liu L; Meewan M; Mohan M; Rock FL; Sexton H; Zhang S; Zhou Y; Wan B; Wang Y; Franzblau SG; Woolhiser L; Gruppo V; Lenaerts AJ; O'Malley T; Parish T; Cooper CB; Waters MG; Ma Z; Ioerger TR; Sacchettini JC; Rullas J; Angulo-Barturen I; Pérez-Herrán E; Mendoza A; Barros D; Cusack S; Plattner JJ; Alley MR
Antimicrob Agents Chemother; 2016 Oct; 60(10):6271-80. PubMed ID: 27503647
[TBL] [Abstract][Full Text] [Related]
20.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
